Disarm Therapeutics
Creating advanced therapeutics to combat axonal degeneration and treat neurological diseases since 2016, based in Cambridge, Massachusetts.
General Information
Get notified when Disarm Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Disarm Therapeutics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Biotechnology
About Disarm Therapeutics
Taxonomy: therapeutics, axonal degeneration, neurological diseases, multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, peripheral neuropathies, disease-modifying drugs, central nervous system, ocular nervous system, peripheral nervous system, Cambridge, Massachusetts, drug development, innovative therapies
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | •••••• | 3 |
|
19 Sep 2017 |
| Grant | •••••• | 1 |
|
01 Aug 2016 |
Disarm Therapeutics Alternatives & Competitors
Pioneering science beyond the brain to treat neurodegenerative diseases at their source
Pioneering a treatment for multiple sclerosis that harnesses the body's innate ability to heal.
Pioneering lipoprotein-receptor drug development to repair damage and degeneration to the brain, spi...
FAQ About Disarm Therapeutics
Don't just browse. Track.
Signal Tracker monitors Disarm Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.